Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News OncoCyte Corp OCX

Healthcare Biotechnology
Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:OCX)

Oncocyte Reports Full Year 2023 Financial Results

GlobeNewswire April 12, 2024

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

GlobeNewswire April 11, 2024

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

GlobeNewswire April 11, 2024

Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire April 9, 2024

Oncocyte to Present at the Sequire Investor Summit in Puerto Rico

GlobeNewswire January 16, 2024

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

GlobeNewswire December 6, 2023

Oncocyte Reports Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Oncocyte to Announce Third Quarter 2023 Financial Results

GlobeNewswire November 3, 2023

Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier

Accesswire September 18, 2023
View More News ››

Opinion & Analysis (NDAQ:OCX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:OCX)

looking good!

looking good the last couple of days! :^)
robertwfb - May 17, 2019
View more Bullboard ››

Steppe Gold Ltd

Steppe Gold Ltd

Steppe Gold Ltd. is engaged in the business of precious metals and minerals exploration sector. Its project includes Altan ...
View More »